Skip to main content
. 2023 Dec 15;39(7):1127–1134. doi: 10.1007/s11606-023-08348-4

Table 2.

Adverse Events per 100 Patient-Years by Testing Location (Unadjusted)

Any event Thromboembolism Major bleed Stroke
PST POC/Lab PST POC/Lab PST POC/Lab PST POC/Lab
All patients 23.7 40.9 6.85 15.2 15.0 24.7 5.22 6.16
Gender
Female 28.9 44.4 9.07 17.4 19.0 27.5 5.3 6.12
Male 19.4 38.3 4.97 13.6 11.7 22.6 5.15 6.19
Age
<65 20.8 40.3 7.22 17.9 11.1 22.3 3.42 4.18
≥65 27.4 42.3 6.35 9.54 20.2 30.2 7.78 10.9
Location
Urban 22.9 40.9 6.66 15.3 14.6 24.9 5.27 6.15
Rural 27.5 40.6 7.86 14.9 16.8 23.5 4.98 6.21
Index diagnosis
AF 21.8 34.6 1.32 2.83 16.8 25.7 7.58 9.66
DVT 32.4 48.1 15.30 23 15.6 23.1 5.49 4.76
MHV 11.2 34.1 0.765 1.28 8.7 27.4 2.44 7.02
PE 38.0 43.9 23.8 31.3 14.4 25.3 3.55 3.92
Payer
Commercial 20.5 40.1 6.83 18.0 11.4 22.2 3.24 4.18
Medicare 27.6 42.3 6.88 9.57 19.6 30.4 7.9 10.9